AngioDynamics reports Q1 2027 results
- Net sales of $80.9M, up 6.9% YoY.
- Med Tech sales up 13.2% to $39.9M.
- Adjusted EBITDA of $5.0M.
Every EDGAR filing for ANGIODYNAMICS INC (ANGO), newest first, with AI summaries and stories.
Next: earnings expected ~Jan 4 ยท 10-Q expected ~Jan 4 (deadline Jan 11)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Warren Nighan JR, insider filing for ANGO
Warren Nighan Jr, reporting
Warren Nighan JR, planned sale of ANGO shares
Warren Nighan Jr, reporting
James C Clemmer, insider filing for ANGO
James C Clemmer, reporting
Wesley Johnson, insider filing for ANGO
Wesley Johnson, reporting
Lawrence T Weiss, insider filing for ANGO
Lawrence T Weiss, reporting
Ownership stake disclosure by Point72 Asset Management, L.P. (amended)
Point72 Asset Management, L.P., filed by
Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
Ownership stake disclosure by Divisadero Street Capital Management, LP (amended)
Divisadero Street Capital Management, LP, filed by
Ownership stake disclosure by SYSTEMATIC FINANCIAL MANAGEMENT LP
SYSTEMATIC FINANCIAL MANAGEMENT LP, filed by
Ownership stake disclosure by Kevin Kotler
Kevin Kotler, filed by
Ownership stake disclosure by INTEGRATED CORE STRATEGIES (US) LLC (amended)
INTEGRATED CORE STRATEGIES (US) LLC, filed by
Ownership stake disclosure by Point72 Asset Management, L.P. (amended)
Point72 Asset Management, L.P., filed by